Skip to main content
. 2023 Jan 5;24:3. doi: 10.1186/s12931-023-02310-y

Fig. 3.

Fig. 3

Treatment with MSC-derived NV resulted in decreased airway inflammation in BAL fluid and lung tissue compared to EV treatment. A, B The total number of inflammatory cells (A) and eosinophils (B) in BAL fluid. C, D The number of T cells (C) and eosinophils (D) that infiltrated into the lung tissues. E, F The level of Eotaxin-2 in BAL fluid (E) and lung tissues (F). Data are presented as the mean ± SEM. *P < 0.05, **P < 0.01 by one-way ANOVA with Tukey’s post test (n = 5)